Board Meeting on November 3, 2026 for Q2 and Half-Year Results; Trading Window Closed

The Board will meet on Tuesday, November 3, 2026 to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2026.

Wed 30 Sep 2026

Board Meeting Date

Tuesday, November 3, 2026

Results Period

Quarter and half year ended September 30, 2026

Trading Window Closure Start

October 1, 2026

Trading Window Reopens

48 hours after results are declared to BSE

What was shared

Novartis India has informed BSE, under Regulation 29 of the SEBI Listing Regulations, that a meeting of its Board of Directors is scheduled for Tuesday, November 03, 2026.

The stated purpose is to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2026.

Trading window

• The trading window for dealing in the company's securities is closed with effect from October 01, 2026.
• It applies to Designated Persons, Insiders, Connected Persons and their immediate relatives.
• It reopens 48 hours after the financial results are declared to BSE.

How to read this

This is an advance intimation of a scheduled board meeting, a standard step companies take before announcing quarterly results. The actual performance figures will only be known when the results are approved and published on the meeting date.

The trading window closure is a routine insider-trading safeguard and does not restrict ordinary public shareholders.

The company has also stated the information is available on its website.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.